All‐cause mortality · people hospitalised with COVID‐19
Higher‐dose anticoagulants showed no clear difference in all‐cause mortality compared with lower‐dose anticoagulants (high certainty).
1 finding from 1 review
Mortality related to COVID‐19 · people hospitalised with COVID‐19
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Deep vein thrombosis · people hospitalised with COVID‐19
It is very uncertain whether anticoagulants changes deep vein thrombosis compared with no treatment (very low certainty).
1 finding from 1 review
Pulmonary embolism · people hospitalised with COVID‐19
It is very uncertain whether anticoagulants changes pulmonary embolism compared with no treatment (very low certainty).
1 finding from 1 review
Major bleeding · people hospitalised with COVID‐19
It is very uncertain whether anticoagulants changes major bleeding compared with no treatment (very low certainty).
1 finding from 1 review
Adverse events (minor bleeding) · people hospitalised with COVID‐19
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Necessity for additional respiratory support · people hospitalised with COVID‐19
It is very uncertain whether higher‐dose anticoagulants changes necessity for additional respiratory support compared with lower‐dose anticoagulants (very low certainty).
1 finding from 1 review
Mortality related to COVID‐19 · people hospitalised with COVID‐19
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Deep vein thrombosis · people hospitalised with COVID‐19
Higher‐dose anticoagulants showed no clear difference in deep vein thrombosis compared with lower‐dose anticoagulants (low certainty).
1 finding from 1 review
Pulmonary embolism · people hospitalised with COVID‐19
Higher‐dose anticoagulants probably leads to lower pulmonary embolism compared with lower‐dose anticoagulants (moderate certainty).
1 finding from 1 review
Major bleeding · people hospitalised with COVID‐19
Higher‐dose anticoagulants probably leads to higher major bleeding compared with lower‐dose anticoagulants (moderate certainty).
1 finding from 1 review
Adverse events (minor bleeding) · people hospitalised with COVID‐19
Higher‐dose anticoagulants leads to higher adverse events (minor bleeding) compared with lower‐dose anticoagulants (high certainty).
1 finding from 1 review
All‐cause mortality · people hospitalised with COVID‐19
It is very uncertain whether anticoagulants changes all‐cause mortality compared with no treatment (very low certainty).
1 finding from 1 review
Necessity for additional respiratory support · people hospitalised with COVID‐19
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number or proportion of cases in the community
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Epidemic growth acceleration
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Exportation growth rate
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
No contributing study
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number or proportion of cases exported
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Intervention not reported
Time to outbreak
1 finding from 1 review
no estimate extracted
Studies not reported
Very low